title: Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
authors.affiliation: University of Cincinnati Medical Center, Ohio 45267-0585, USA.
authors.forename: M R
authors.initials: MR
authors.lastname: First
authors.forename: P
authors.initials: P
authors.lastname: Weiskittel
authors.forename: M
authors.initials: M
authors.lastname: Shah
authors.forename: V R
authors.initials: VR
authors.lastname: Peddi
authors.forename: D
authors.initials: D
authors.lastname: Canafax
authors.forename: T J
authors.initials: TJ
authors.lastname: Schroeder
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001682:Biological Availability; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine